504 related articles for article (PubMed ID: 23648711)
1. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study.
Lai HC; Lin CC; Cheng KS; Kao JT; Chou JW; Peng CY; Lai SW; Chen PC; Sung FC
Gastroenterology; 2014 Jan; 146(1):129-37.e1. PubMed ID: 24095786
[TBL] [Abstract][Full Text] [Related]
3. Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
Lin CM; Huang HL; Chu FY; Fan HC; Chen HA; Chu DM; Wu LW; Wang CC; Chen WL; Lin SH; Ho SY
PLoS One; 2015; 10(5):e0125421. PubMed ID: 25978841
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan.
Liao KF; Lai SW; Li CI; Chen WC
J Gastroenterol Hepatol; 2012 Apr; 27(4):709-13. PubMed ID: 21929650
[TBL] [Abstract][Full Text] [Related]
5. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.
Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH
J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226
[TBL] [Abstract][Full Text] [Related]
6. A population-based cohort study in Taiwan--use of insulin sensitizers can decrease cancer risk in diabetic patients?
Kao CH; Sun LM; Chen PC; Lin MC; Liang JA; Muo CH; Chang SN; Sung FC
Ann Oncol; 2013 Feb; 24(2):523-530. PubMed ID: 23110810
[TBL] [Abstract][Full Text] [Related]
7. Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan.
Hsiao PJ; Wu KL; Chiu SH; Chan JS; Lin YF; Wu CZ; Wu CC; Kao S; Fang TC; Lin SH; Chen JS
Clin Exp Nephrol; 2017 Aug; 21(4):694-704. PubMed ID: 27599981
[TBL] [Abstract][Full Text] [Related]
8. Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: A population-based study in Taiwan.
Tseng CM; Liao WC; Chang CY; Lee CT; Tseng CH; Hsu YC; Lin JT
Pancreatology; 2017; 17(1):76-82. PubMed ID: 27743712
[TBL] [Abstract][Full Text] [Related]
9. Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study.
Lee YC; Chang CH; Dong YH; Lin JW; Wu LC; Hwang JS; Chuang LM
Int J Cardiol; 2017 Feb; 228():1007-1014. PubMed ID: 27923207
[TBL] [Abstract][Full Text] [Related]
10. Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; McWilliams RR; Chari ST
Am J Gastroenterol; 2013 Apr; 108(4):510-9; quiz 520. PubMed ID: 23399556
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of Diabetes Mellitus on Overall Survival in a Nationwide Population-Based Cohort of Patients With Pancreatic Cancer.
Tseng CM; Wang HH; Wang WL; Lee CT; Tai CM; Tseng CH; Chen CC; Tsai YN; Sun MS; Hsu YC
Endocr Pract; 2020 Jul; 26(7):707-713. PubMed ID: 33471638
[TBL] [Abstract][Full Text] [Related]
12. Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias.
Bowker SL; Lin M; Eurich DT; Johnson JA
Can J Diabetes; 2017 Apr; 41(2):204-210. PubMed ID: 27908558
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
[TBL] [Abstract][Full Text] [Related]
14. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.
Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM; Chan KA
Hepatology; 2012 May; 55(5):1462-72. PubMed ID: 22135104
[TBL] [Abstract][Full Text] [Related]
15. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan.
Chen YL; Cheng KC; Lai SW; Tsai IJ; Lin CC; Sung FC; Lin CC; Chen PC
Gastric Cancer; 2013 Jul; 16(3):389-96. PubMed ID: 23053824
[TBL] [Abstract][Full Text] [Related]
17. Risk of acute epiglottitis in patients with preexisting diabetes mellitus: A population-based case-control study.
Tsai YT; Huang EI; Chang GH; Tsai MS; Hsu CM; Yang YH; Lin MH; Liu CY; Li HY
PLoS One; 2018; 13(6):e0199036. PubMed ID: 29889887
[TBL] [Abstract][Full Text] [Related]
18. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Nie SP; Chen H; Zhuang MQ; Lu M
Asian Pac J Cancer Prev; 2014; 15(16):6863-9. PubMed ID: 25169538
[TBL] [Abstract][Full Text] [Related]
19. Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus.
Sun GE; Wells BJ; Yip K; Zimmerman R; Raghavan D; Kattan MW; Kashyap SR
Diabetes Obes Metab; 2014 Mar; 16(3):276-83. PubMed ID: 24199848
[TBL] [Abstract][Full Text] [Related]
20. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.
Lu HL; Su YC; Lin MC; Sun MF; Huang ST
Complement Ther Med; 2020 Mar; 49():102332. PubMed ID: 32147062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]